William Rapeport
Nessuna posizione attualmente
Storia della carriera di William Rapeport
Precedenti posizioni note di William Rapeport
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 23/03/2007 | 19/12/2019 |
| Amministratore Delegato | 23/03/2007 | 19/12/2019 | |
| Direttore Tecnico/Scientifico/R&S | 23/03/2007 | 19/12/2019 | |
| Fondatore | 23/03/2007 | 19/12/2019 | |
| GALAPAGOS NV | Direttore/Membro del Consiglio | 06/07/2009 | 30/06/2010 |
| GSK PLC | Corporate Officer/Principal | - | - |
| Glaxo Wellcome Plc | Corporate Officer/Principal | 01/01/1996 | - |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/1988 | - |
RespiVert Ltd.
 RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 01/11/2006 | - |
| Amministratore Delegato | 01/11/2006 | - | |
| Fondatore | 01/11/2006 | - |
Formazione di William Rapeport
| University of Glasgow | Undergraduate Degree |
| University of Oxford | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 7 |
| Belgio | 2 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| GALAPAGOS NV | Health Technology |
| PFIZER, INC. | Health Technology |
| GSK PLC | Health Technology |
| Aziende private | 3 |
|---|---|
RespiVert Ltd.
RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom. | Distribution Services |
Pulmocide Ltd.
Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Health Technology |
| Glaxo Wellcome Plc | Health Technology |
- Borsa valori
- Insiders
- William Rapeport
- Esperienza
